Researcher
Benedicte De Winter
- Research Expertise:- Visceral pain - Inflammation - ileus - irritable bowel syndrome - IBS - inflammatory bowel disease - IBD - sepsis - experimental and clinical translational research - medisch vaardighedenonderwijs
- Keywords:VISCERAL PAIN, SEPSIS, IRRITABLE BOWEL SYNDROME, INFLAMMATION, INFLAMMATORY BOWEL DISEASE, Medicine
- Disciplines:Gastro-enterology, Inflammation, Pathophysiology
- Research techniques:- in vivo animal models of IBS, IBD and sepsis - visceromotor response and afferent neuronal activity - motility and sensitivity assays - inflammation measurements - Elisa, flowcytometry - vaardigheden, portfolio, stationsproeven
- Users of research expertise:- research labs - pharmaceutical industry - (bio-, para-) medical schools
Affiliations
- Laboratory Experimental Medicine and Pediatrics (LEMP) (Research group)
Responsible
From1 Oct 2013 → Today - Laboratory Experimental Medicine and Pediatrics (LEMP) (Research group)
Member
From1 Oct 2003 → 30 Sep 2013 - Primary and interdisciplinary care Antwerp (ELIZA) (Research group)
Member
From1 Oct 2003 → 30 Sep 2008
Projects
1 - 10 of 32
- Automation of a mucin mRNA isoform-based biomarker platform to monitor patients with inflammatory bowel diseases.From1 Apr 2024 → TodayFunding: IOF - technology validation in lab
- Crosstalk between MUC13 signalling and the mucosal microbiota in gastric cancer development.From1 Jan 2024 → TodayFunding: Nonprofit institution or equivalents
- REspiratory Virus Repository ANTwerp (ReViRAnt).From1 Jan 2023 → TodayFunding: Flemish Resilience. Government of Flanders Recovery Plan - strengthening R&D
- Turning the understanding of inflammation-related pathology into new biomarkers and treatments using next-generation technologies and high-throughput data mining.From1 Nov 2022 → TodayFunding: BOF - postdoctoral mandates
- A mucin mRNA isoform-based biomarker assay to improve treatment response in patients with inflammatory bowel diseases.From1 Sep 2022 → 31 Aug 2023Funding: IOF - technology validation in lab
- High-end comprehensive GCxGC-QTOF-MS research facility for volatile and semivolatile compounds (GALILEO).From1 Jun 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Assessing health effects of air pollution by non-invasive exhaled breath analysis (ALERT).From1 Jun 2021 → 31 May 2023Funding: Provinces
- Mucin isoform-microbiome crosstalk shaping the course of COVID-19: a help in patient stratification?From1 Nov 2020 → 31 Oct 2021Funding: FWO Special Call for Covid-19 research projects, BOF - projects
- Study of the mechanisms involved in MUC1/MUC13-induced intestinal barrier disruption during inflammatory bowel diseases: a translational approach.From1 Nov 2020 → TodayFunding: FWO junior postdoctoral fellowship
- Functional characterization of human mast cells and basophils in the pathophysiology of diarrhea-predominant irritable bowel syndrome.From1 Oct 2020 → 30 Sep 2022Funding: FWO fellowships
Publications
141 - 150 of 165
- Chronic alcohol consumption affects gastrointestinal motility and reduces the proportion of neuronal NOS-immunoreactive myenteric neurons in the murine jejunum(2010)
Authors: María Bagyánszki, Mónika Krecsmarik, Benedicte De Winter, Joris De Man, Éva Fekete, Alfons B.A. Kroese, Jean-Pierre Timmermans
Pages: 1536 - 1542 - Validity study of workplace-based portfolio-assessment via a Delphi procedure at Medical School, University of Antwerp (Belgium)(2010)
Authors: Nele Michels, Joke Denekens, L. Driessen, Leo Bossaert, Benedicte De Winter
Number of pages: 1 - Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation **in vitro** and **in vivo** in a rat model(2010)
Authors: Sven Francque, Sam Wamutu, Shyama Ghosh, Arnold Herman, Albert Ramon, Alexander Jung, Wim Vermeulen, Benedicte De Winter
Pages: 365 - 375 - Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility(2010)
Authors: Benedicte De Winter, Joris De Man
Pages: 5523 - 5535 - Portfolio in medisch onderwijs: implementatie in het stagejaar(2010)
Authors: Nele Michels, Leo Bossaert, Benedicte De Winter
Pages: 386 - 393 - **Schistosoma mansoni** proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice(2010)
Authors: Nathalie E. Ruyssers, Benedicte De Winter, Joris De Man, Natacha D. Ruyssers, Ann J. van Gils, Alex Loukas, Mark S. Pearson, Joel V. Weinstock, Tom Moreels
Pages: 703 - 712 - Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice(2009)
Authors: Nathalie E. Ruyssers, Benedicte De Winter, Joris De Man, Alex Loukas, Mark S. Pearson, Joel V. Weinstock, Rita M. van den Bossche, Wim Martinet, Tom Moreels
Pages: 491 - 500 - Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings(2009)
Authors: H. Piessevaux, Benedicte De Winter, E. Louis, V. Muls, D. de Looze, M. Deltenre, D. Urbain, J. Tack
Pages: 378 - 388 - Learning intimate examinations with simulated patients: the evaluation of medical students' performance(2009)
Authors: Kristin Hendrickx, Benedicte De Winter, Wiebren Tjalma, Dirk Avonts, Griet Peeraer, Jean Jacques Wyndaele
Pages: 139 - 147 - Medical faculty's conceptions on learning and how they approach teaching(2009)
Authors: Griet Peeraer, Vincent Donche, Benedicte De Winter, A.M.M. Muijtjens, Peter Van Petegem
Pages: 248 - 249
Patents
1 - 9 of 9
- Method for determining the severity and prognosis of rsv infection (Inventor)
- Mucins and isoforms thereof in diseases characterized by barrier dysfunction (Inventor)
- Mucin isoforms in diseases characterized by barrier dysfunction (Inventor)
- Mucins and isoforms thereof in diseases characterized by barrier dysfunction (Inventor)
- Method for determining the severity and prognosis of RSV infection (Inventor)
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases. (Inventor)
- Mucin isoforms in diseases characterized by barrier dysfunction (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
Linked dataset
1 - 1 of 1